FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On November 15, 2007
Docket # Title
1978N-0038 Sunscreen Drug Products
2000N-0504 Egg Safety Action Plan
2005H-0271 Civil Money Penalty: TMJ Implants, Inc.
2006N-0168 Food Labeling: Reference Daily Intakes & Daily Reference Values
2007D-0310 Companion to Guidance for Industry on Pharmacogenomic Data
2007N-0277 Food Labeling: Use of Symbols to Communicate Nutrition Information, Consideration of Consumer Studies and Nutritional Criteria; Public Hearing
2007N-0356 BEHIND THE COUNTER AVAILABILITY OF CERTAIN DRUGS; Public Meeting
2007N-0382 Ramipril Capsules and 180-day generic drug exclusivity
2007P-0450 Determine whether a 200 mg/ vial presentation of Oxaliplatin for Injection (lyophilized powder for infusion) may be file as an Abbreviated New Drug Application Suitability
2007V-0451 Laser Light Show
1978N-0038 Sunscreen Drug Products
EC 2658 Mrs. Sheila Bishoff Vol #: 163
EC 2659 Ms. C.J. Meakes Vol #: 163
2000N-0504 Egg Safety Action Plan
MM 1 Renee J. Wheeler Vol #: 32
2005H-0271 Civil Money Penalty: TMJ Implants, Inc.
BRF 4 TMJ Implants, Inc. Vol #: 245
LET 10 TMJ Implants, Inc. Vol #: 245
LET 11 TMJ Implants, Inc. Vol #: 245
2006N-0168 Food Labeling: Reference Daily Intakes & Daily Reference Values
EC 89 Mrs. Mary Strickland Vol #: 1
EC 90 Mr. William Babb Vol #: 1
EC 91 Mr. Matthew Vessey Vol #: 1
2007D-0310 Companion to Guidance for Industry on Pharmacogenomic Data
C 2 Chinying Wang Vol #: 1
2007N-0277 Food Labeling: Use of Symbols to Communicate Nutrition Information, Consideration of Consumer Studies and Nutritional Criteria; Public Hearing
C 3 The Sugar Association Vol #: 4
2007N-0356 BEHIND THE COUNTER AVAILABILITY OF CERTAIN DRUGS; Public Meeting
APE 2 M. M. Stryzak Vol #: 1
EC 58 Castlerock Medical Vol #: 2
EC 59 Ms. Karen Livanis Vol #: 2
2007N-0382 Ramipril Capsules and 180-day generic drug exclusivity
ACK 2 Number not used Vol #: 1
2007P-0450 Determine whether a 200 mg/ vial presentation of Oxaliplatin for Injection (lyophilized powder for infusion) may be file as an Abbreviated New Drug Application Suitability
ACK 1 FDA/DDM to Ebewe Parenta Pharmaceuticals, Inc. Vol #: 1
CP 1 Ebewe Parenta Pharmaceuticals, Inc. Vol #: 1
2007V-0451 Laser Light Show
ACK 1 FDA/DDM to Mountain Megabytes Inc. Vol #: 1
VAR 1 Mountain Megabytes Inc. Vol #: 1

Page created on November 15, 2007 ue

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management